Company profile: Althea Technologies
1.1 - Company Overview
Company description
- Provider of contract manufacturing services to the pharmaceutical and biotechnology industries, offering gene expression analysis via eXpress Profiling, quantitative PCR testing, cGMP drug product filling in vials and syringes, and production of microbial-derived recombinant proteins and plasmid DNA.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Althea Technologies
Noble Pharma
HQ: United States
Website
- Description: Provider of FDA-approved contract development and manufacturing services for extremely palatable animal health products, including formulation and process development; manufacturing of soft chews, creams, ointments, suspensions, tablets, powders, and pastes; clinical supplies; GLP analytical and ICH stability services; regulatory support; packaging with serialization and child-resistant options; and technology transfer and validation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Noble Pharma company profile →
TKL Research
HQ: United States
Website
- Description: Provider of a fully integrated network of clinical research centers serving pharmaceutical, biotechnology, medical device, and consumer healthcare industries, offering inpatient and outpatient capabilities, including two purpose-built phase I clinical pharmacology units and five outpatient clinics equipped for phase II–IV clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TKL Research company profile →
Peptido
HQ: Germany
Website
- Description: Provider of GMP-compliant synthesis of pharmaceutical active ingredients, delivering services from lab-scale and pilot quantities to industrial-scale production for the pharmaceutical industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Peptido company profile →
Surface Ophthalmics
HQ: United States
Website
- Description: Provider of ophthalmic therapeutics leveraging the Klarity delivery vehicle, including SURF-100 topical eyedrops for chronic dry eye (Phase II), SURF-200 for acute dry eye (Phase II), SURF-201 Betamethasone 0.2% solution for post-cataract pain and inflammation (positive Phase II), and an MPA 0.1% chronic dry eye therapy ready for Phase III.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Surface Ophthalmics company profile →
Lyophilization Services
HQ: United States
Website
- Description: Provider of lyophilization services to the pharmaceutical, biotechnology, and medical device industries, producing products in a timely, reliably consistent, GMP-compliant manner with a focus on quality and patient safety.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lyophilization Services company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Althea Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Althea Technologies
2.2 - Growth funds investing in similar companies to Althea Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Althea Technologies
4.2 - Public trading comparable groups for Althea Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →